Long-term safety tracking for blood cancer patients treated with CAR-T therapy

This is a long-term safety study of Kymriah, a specialized type of cancer treatment that uses your own immune cells to fight certain blood cancers. Researchers want to understand how safe this medication is over many years and whether it works well in real-world situations—not just in controlled clinical trials. You would be part of a registry (a database) where your health information is tracked and monitored.

While this medication has shown promise in treating certain blood cancers, doctors need to understand its long-term effects over many years—including whether it might raise the risk of developing other cancers later. This study will give researchers real-world information to help keep patients safe and informed.